CS
Citrate synthase, mitochondrial
Also known as: CISY_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O75390
- Gene
- CS
- Ensembl
- ENSG00000062485
- Chromosome
- 12
- Canonical length
- 466 aa
- Protein class
- Citric acid cycle related proteins, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Mitochondria
- Quaternary structure
- Homodimer
OverviewNCBI Gene
The protein encoded by this gene is a Krebs tricarboxylic acid cycle enzyme that catalyzes the synthesis of citrate from oxaloacetate and acetyl coenzyme A. The enzyme is found in nearly all cells capable of oxidative metablism. This protein is nuclear encoded and transported into the mitochondrial matrix, where the mature form is found. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
466 residues, UniProt reviewed canonical sequence.
>O75390|CS
1 MALLTAAARL LGTKNASCLV LAARHASASS TNLKDILADL IPKEQARIKT FRQQHGKTVV
61 GQITVDMMYG GMRGMKGLVY ETSVLDPDEG IRFRGFSIPE CQKLLPKAKG GEEPLPEGLF
121 WLLVTGHIPT EEQVSWLSKE WAKRAALPSH VVTMLDNFPT NLHPMSQLSA AVTALNSESN
181 FARAYAQGIS RTKYWELIYE DSMDLIAKLP CVAAKIYRNL YREGSGIGAI DSNLDWSHNF
241 TNMLGYTDHQ FTELTRLYLT IHSDHEGGNV SAHTSHLVGS ALSDPYLSFA AAMNGLAGPL
301 HGLANQEVLV WLTQLQKEVG KDVSDEKLRD YIWNTLNSGR VVPGYGHAVL RKTDPRYTCQ
361 REFALKHLPN DPMFKLVAQL YKIVPNVLLE QGKAKNPWPN VDAHSGVLLQ YYGMTEMNYY
421 TVLFGVSRAL GVLAQLIWSR ALGFPLERPK SMSTEGLMKF VDSKSGLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CS can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 561 nTPM
Expression across tissuesHPA
Tissue
- tongue: 561 nTPM
- skeletal muscle: 515 nTPM
- heart muscle: 299 nTPM
- adipose tissue: 145 nTPM
- parathyroid gland: 120 nTPM
- retina: 120 nTPM
Single-cell type
- myonuclei: 132 nCPM
- cardiomyocytes: 126 nCPM
- parietal cells: 126 nCPM
- esophageal apical cells: 116 nCPM
- thymic myoid cells: 105 nCPM
- adipocytes: 94 nCPM
Immune cell
- eosinophil: 207 nTPM
- myeloid DC: 120 nTPM
- non-classical monocyte: 95 nTPM
- intermediate monocyte: 93 nTPM
- classical monocyte: 74 nTPM
- total PBMC: 72 nTPM
Brain region
- cerebral cortex: 131 nTPM
- thalamus: 116 nTPM
- choroid plexus: 115 nTPM
- pons: 111 nTPM
- medulla oblongata: 103 nTPM
- hypothalamus: 102 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.3
- gnomAD pLI
- 0.98
- gnomAD missense Z
- 3.33
- DepMap mean gene effect
- -0.42
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- identical protein binding
- RNA binding
- citrate synthase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Citrate synthase
- Citrate synthase-like, small alpha subdomain
- Citrate synthase superfamily
- Citrate synthase, C-terminal domain
- Citrate synthase, eukaryotic-type
- Citrate synthase-like, large alpha subdomain
- Citrate synthase active site
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CS as an antibody target. Whether an autoantibody or antibody against CS could matter depends on whether native CS is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CS is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CS as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...